Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott A Stuart

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|April 1, 2009
Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cellsScott A Stuart, Jean Y J Wang
Cell Cycle (Georgetown, Tex.)|April 4, 2009
The CML stem cell: evolution of the progenitorScott A Stuart, Yosuke Minami, Jean Y J Wang
Pharmacogenomics|June 12, 2026
Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery modelsEmily Huang, Aniwaa Owusu Obeng, Scott A Stuart, et al.
Molecular & Cellular Proteomics : MCP|April 9, 2015
A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma CellsScott A Stuart, Stephane Houel, Thomas Lee, et al.
Journal of the American Society for Mass Spectrometry|April 9, 2015
Large-Scale Examination of Factors Influencing Phosphopeptide Neutral Loss during Collision Induced DissociationRobert Brown, Scott A Stuart, Scott S Stuart, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2022
Intermittent treatment of BRAF<sup>V600E</sup> melanoma cells delays resistance by adaptive resensitization to drug rechallengeAndrew J Kavran, Scott A Stuart, Kristyn R Hayashi, et al.
Molecular & Cellular Proteomics : MCP|December 20, 2017
Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma CellsJoel Basken, Scott A Stuart, Andrew J Kavran, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
BCR-ABL-transformed GMP as myeloid leukemic stem cellsYosuke Minami, Scott A Stuart, Tomokatsu Ikawa, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|April 1, 2009
Ionizing radiation induces ATM-independent degradation of p21Cip1 in transformed cellsScott A Stuart, Jean Y J Wang
Cell Cycle (Georgetown, Tex.)|April 4, 2009
The CML stem cell: evolution of the progenitorScott A Stuart, Yosuke Minami, Jean Y J Wang
Pharmacogenomics|June 12, 2026
Optimizing pharmacogenomics workflows: a qualitative evaluation of clinical service delivery modelsEmily Huang, Aniwaa Owusu Obeng, Scott A Stuart, et al.
Molecular & Cellular Proteomics : MCP|April 9, 2015
A Phosphoproteomic Comparison of B-RAFV600E and MKK1/2 Inhibitors in Melanoma CellsScott A Stuart, Stephane Houel, Thomas Lee, et al.
Journal of the American Society for Mass Spectrometry|April 9, 2015
Large-Scale Examination of Factors Influencing Phosphopeptide Neutral Loss during Collision Induced DissociationRobert Brown, Scott A Stuart, Scott S Stuart, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 15, 2022
Intermittent treatment of BRAF<sup>V600E</sup> melanoma cells delays resistance by adaptive resensitization to drug rechallengeAndrew J Kavran, Scott A Stuart, Kristyn R Hayashi, et al.
Molecular & Cellular Proteomics : MCP|December 20, 2017
Specificity of Phosphorylation Responses to Mitogen Activated Protein (MAP) Kinase Pathway Inhibitors in Melanoma CellsJoel Basken, Scott A Stuart, Andrew J Kavran, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 14, 2008
BCR-ABL-transformed GMP as myeloid leukemic stem cellsYosuke Minami, Scott A Stuart, Tomokatsu Ikawa, et al.
Pageof 1